DoH drugs plan could raise NHS costs

DoH plans for 'value-based pricing' of drugs could increase costs without improving treatment effectiveness, the NHS Confederation has warned.

Nigel Edwards: a good idea has turned into poor policies (Photograph: NHS Confederations)
Nigel Edwards: a good idea has turned into poor policies (Photograph: NHS Confederations)

Responding to a recent consultation on the plans, the body said drugs given a value-based price may still represent poor value for money when compared with other treatments.

For instance, early detection or surgery can be more effective investments than many high-cost cancer drugs that provide late-stage respite for patients at the end of their lives, it argued.

The DoH believes the policy will give patients and clinicians greater access to medicines, based on an assessment of the outcomes that they can achieve.

Nigel Edwards, acting chief executive of the NHS Confederation, said: 'The current process is not perfect and pricing based on value is good in principle. But this is a case of a good idea that has turned into poor policy.

'We simply don't see that the process suggested will achieve what the government wants.'

The scheme aims to reward pharmaceutical companies for innovating and creating breakthrough drugs. But the NHS Confederation claimed that the amount of money the NHS spends on drugs is not 'of a sufficient scale to affect the behaviour of a sector populated by multinational organisations with annual turnovers of tens of billions of dollars'.

Instead, NICE should be allowed to develop a more rigorous method for assessing value-based pricing, it said.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Redacting information from medical records - advice for GPs

Redacting information from medical records - advice for GPs

MDU medico-legal adviser Dr Ellie Mein provides advice for GPs on reacting information...

Medicine shortages set to continue despite Brexit delay

Medicine shortages set to continue despite Brexit delay

Medicine shortages are unlikely to improve as a result of Brexit being delayed healthcare...

Doctors less likely to be investigated for 'one-off' mistakes under new GMC rules

Doctors less likely to be investigated for 'one-off' mistakes under new GMC rules

The GMC is introducing new measures to reduce the number of full investigations in...

RCGP revokes Sultan of Brunei's honorary title over anti-LGBTQ laws

RCGP revokes Sultan of Brunei's honorary title over anti-LGBTQ laws

The RCGP has revoked the honorary title it awarded the Sultan of Brunei following...

Financial considerations for primary care networks

Financial considerations for primary care networks

Specialist accountant Laurence Slavin highlights the financial issues that practices...

Number of CCGs could be cut by 75% by April 2020

Number of CCGs could be cut by 75% by April 2020

Measures to cut the number of CCGs in England by more than three quarters could be...